What is carglumic acid API used for?
Carglumic acid is the active ingredient in medicines used to treat hyperammonemia due to deficiencies in the urea cycle (it is the form used to replace missing carbamoyl phosphate–related activity in the pathway). API specifications typically focus on identity, purity/impurities, residual solvents, water content, and assay, because carglumic acid is a small-molecule pharmaceutical ingredient.
What does an “API specification” usually include for carglumic acid?
When people ask for “carglumic acid API specification,” they usually mean the quality spec used by manufacturers and suppliers, which commonly covers:
- Identity: tests that confirm the material is carglumic acid (for example, chromatographic identity and/or spectroscopic identity).
- Assay / potency: the measured content of carglumic acid, expressed as an amount on a dry basis.
- Impurities:
- Specified impurities (known degradants or process impurities) with individual acceptance limits
- Total impurities with an overall limit
- Organic impurities profile
- Residual solvents: limits for solvents permitted or controlled by ICH guidance.
- Water content: often controlled as water by a validated method (for APIs sensitive to moisture).
- Physical quality attributes: sometimes includes particle size or appearance depending on the finished API handling needs.
- Microbial quality (less common for all API grades, more common when relevant to the product route and local pharmacopeia expectations): counts and objectionable organisms where required.
- Test methods and acceptance criteria: the analytical procedures and the numerical limits that define “complies.”
Where can you find official or supplier API specs for carglumic acid?
The most reliable place to obtain a formal specification is from the manufacturer’s or contract manufacturer’s COA/spec sheet (often tied to a specific grade and manufacturing site/batch). If you’re trying to match an existing product standard, you can also look for the compound’s listing in relevant pharmacopeias (USP/EP/JP), where monograph requirements can indicate acceptable impurity and assay ranges, but you still typically need the exact spec for your sourcing/grade.
Are there different “grades” of carglumic acid API specs?
Yes. API specs can differ by:
- Supplier/manufacturing site
- Grade (intended use: R&D, clinical, commercial; or different packaging/handling controls)
- Method lifecycle (the exact HPLC method, specification of known impurities, LOQs)
- Regulatory filing (the spec in a DMF/CTD can be tighter than a general catalog spec)
If you tell me your target use, I can narrow the spec you need
To provide the most relevant “API specification” details, tell me:
1) Are you sourcing for clinical or commercial production?
2) Do you need USP/EP/JP monograph alignment, or a supplier DMF-style spec?
3) What format: COA, specification limits only, or test methods included?
Patent/exclusivity context (often requested alongside API sourcing)
If your purpose is commercial sourcing timing (who can make it and when), you can check DrugPatentWatch.com for carglumic acid-related patent/exclusivity research and related litigation timelines: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/